Axovant Gene Therapies Strengthens Board of Directors and Announces New Chief...
NEW YORK, Oct. 08, 2020 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced the...
View ArticleClik here to view.
Third Quarter Earnings – A Perfect Messaging Opportunity, but Make it Quick.
With earnings season right around the corner, many companies are putting final thoughts into their third quarter earnings materials and investors are taking out their 2020 checklists. Earnings...
View ArticleEnlivex: After Expedited Review, Israeli Ministry of Health Authorizes...
Nes Ziona, Israel, Oct. 13, 2020 (GLOBE NEWSWIRE) — Enlivex Therapeutics Ltd. (Nasdaq: ENLV, the “Company”), a clinical-stage immunotherapy company, today reported that the Israeli Ministry of Health...
View ArticleDarioHealth Announces Inclusion of its Digital Therapeutics Platform in...
NEW YORK, Oct. 13, 2020 /PRNewswire/ — DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company’s digital therapeutics...
View ArticleBrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive...
CRESSKILL, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
View ArticleelectroCore Provides Business Update and Select Financial Guidance
BASKING RIDGE, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) — electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as...
View ArticleCidara Therapeutics to Present at the 2020 American College of Clinical...
SAN DIEGO, Oct. 13, 2020 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics designed to transform the standard of care for patients...
View ArticleAxovant Gene Therapies Receives Rare Pediatric Disease Designation for...
NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) — Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced that it...
View ArticleClik here to view.
Eyenovia to Host Investor Call to Discuss Recent Licensing Agreements...
NEW YORK, Oct. 13, 2020 (GLOBE NEWSWIRE) — Eyenovia, Inc., (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose array print (MAP) therapeutics, today...
View ArticleClik here to view.
10 Tips for Non-Deal Roadshows
Developing and executing on an effective corporate access plan is a key component of any investor relations strategy to increase awareness of and generate interest in your company’s story with the...
View Article